🏥 Private Equity in Healthcare: A Sector-Specific Downturn Recent data from PitchBook highlights a notable trend: Private equity's retreat from certain segments of the healthcare industry is more pronounced than in other sectors. 🔍 Key Insights: 1️⃣ In healthcare services and health-focused IT, deal numbers hit new lows in Q2 2023, plummeting over 70% from their peak in 2021. 2️⃣ Comparatively, PE dealmaking across all sectors has seen a 29% drop since its Q4 2021 high. 3️⃣ A consistent valuation mismatch is hindering deal-making across industries. 4️⃣ In healthcare services, high debt-servicing costs, especially in areas like dental, vision, and veterinary care, are limiting add-on deals. 5️⃣ A notable example of this trend is the dissolution of Carlyle's plan to acquire a stake in Cotiviti, a deal that would've been worth around $15 billion. Furthermore, corporate M&A activity in the healthcare IT sector has slowed even more drastically than PE deals. In H1 2023, only $500 million in deals were made across 37 transactions, a stark contrast to the $44 billion across 134 deals in 2022. The healthcare sector, with its unique challenges and opportunities, is undergoing a significant transformation in the PE landscape. Stakeholders need to be agile and adaptive in this evolving scenario. Read more at: https://lnkd.in/gcXNDS6w #PrivateEquity #HealthcareIndustry #MergersAndAcquisitions #PitchBookData
Mauch Business Solutions’ Post
More Relevant Posts
-
The healthcare M&A and private equity space is feeling the pinch. Down more than 70% from peak dealmaking times in the fourth and second quarters of 2021. #healthcare #privateequity https://lnkd.in/em7U_EpT
Private equity healthcare dealmaking keeps falling | PitchBook
pitchbook.com
To view or add a comment, sign in
-
Healthcare among the hardest hit sectors for M&A activity with deal volume down across the board "...PE dealmaking in the broader market across all sectors has fallen by an estimated 29% from its high in Q4 2021..." Although comparing any year to 2021 might be misguided. Perhaps not all doom and gloom - we are seeing activity pick up again in certain areas. https://lnkd.in/ebXe2mUT
Private equity healthcare dealmaking keeps falling | PitchBook
pitchbook.com
To view or add a comment, sign in
-
Discover how @LatticeworkCapital's new $345M LCM Healthcare Fund II is set to accelerate growth in lower middle-market healthcare companies. #PrivateEquity #HealthcareInvestment #GrowthCapital
Capital boost for founder-led healthcare ventures: Dallas Latticework Fund closes
https://funderlyst.com
To view or add a comment, sign in
-
While analysts expect PE healthcare managers to continue to deploy capital into current portfolio companies and into lower-middle-market acquisitions, they also note that the nature of PE healthcare investing is changing. https://lnkd.in/d-hKAadW?
Healthcare PE investors proceed with caution in 2024
pitchbook.com
To view or add a comment, sign in
-
Great conference by McDermott Will & Emery in #London on topics concerning #privateequity #healthcare #investors Key insights: 1. Deal sectors: Pharma services remains a strong sector, in addition to MedTech, Life sciences tools, Specialty pharma 2. "Take-private' becoming attractive with examples of deals happening in Pharma services (ARCHIMED-Instem, ERGOMED-Permira) and other sectors 3. Getting deals done in current environment involves using mechanisms as earn-outs, fund facilities, vendor loans 4. Anti-trust scrutiny increasing even for financial sponsor backed deals 5. Strong pitching activity, #deal pipelines with #investmentbanks 6. "Expect to see 20 SIMs on your desks" - in coming months as summarised by a #healthcarebanker 7. General consensus that Q4 #jefferies, Q1 #JPM will be busy for #healthcare deals Medi-Tech Insights #manda #acquisitions #healthcare #privateinvestors
To view or add a comment, sign in
-
-
We are pleased to release our review of M&A, private equity and venture capital activity across the UK healthcare sector in Q1 of 2024. Our report, which can be found below, highlights the most active sub-sectors, along with a month-by-month summary of the key deals across the market. #healthcare #privateequity #venturecapital #corporatefinance #investmentbanking #mergersandacquisitions #mergersacquisitionsdivestitures
To view or add a comment, sign in
-
Private equity firms are showing significant interest in RCM companies, with a surge in activity seen throughout 2023 and into 2024. In 2022 alone, RCM companies were involved in 21 private equity deals, including 18 add-ons and three buyouts. Recent highlights include: > Aquiline Capital Partners Partners' investment in Health Prime International and acquisition of a stake from GPB Capital for US$190 million in 2024. > New Mountain Capital's offer to buy out the remaining ownership of R1 RCM at a staggering US$5.8 billion in 2024. > TA Associates' substantial growth investment in Alpha II - Healthcare RCM, a leading provider of RCM technology solutions to healthcare providers, in 2023. > ECLAT Health Solutions Inc, a portfolio company of Gulf Capital, acquiring the Health Information Management (HIM) division of Excite Health Partners in 2023. > WellSky, a portfolio company of Leonard Green & Partners (LGP) and TPG Capital, expanding its medical coding and RCM offerings with the acquisition of Corridor from HealthEdge Investment Partners in 2023. The question arises: why is this happening, and how will it impact the industry? Find out more in this insightful blog by my colleague Vivek Kumar https://lnkd.in/gQc2FCH5 #RCM #PrivateEquity #HealthcareInvestments #IndustryTrends #EverestGroup #TheHealthcareAnalyst
To view or add a comment, sign in
-
This morning's $395m* acquisition of Healthia by Pacific Equity Partners is a text-book example of the value accretion availed from acquiring small entities and bundling them into a bigger entity and generating value in the process. Healthia's, a 334 clinic business, will trade at 10.3x EBITDA multiple, Back in Motion's 74 clinics traded at 7.2x EBITDA multiple and the much smaller acquisitions traded at circa 5x EBITDA multiple. Why do we get higher valuations for bigger businesses but all else being equal? Partly it is reduced risk (small businesses have key person reliance and high revenue leakage risk). But the biggest factor is that Institutional Investors (where the big money goes) only want to write big cheques, that's their economic model. What does this tell you? There's always going to be better value / better returns investing into small and emerging businesses .... for those who are comfortable with that level of risk and illiquidity. This is not investment advice and investing into emerging businesses is a bad idea for most people. * $395m Enterprise Value comprised $252m in ordinary shares, $38m in Clinic shares and $103m in borrowings & performance rights.
To view or add a comment, sign in
-
-
We are pleased to release our review of M&A, private equity and venture capital activity across the UK healthcare sector in Q2 of 2024. Our report, which can be found below, highlights the most active sub-sectors, along with a month-by-month summary of the key deals across the market. #healthcare #privateequity #venturecapital #corporatefinance #investmentbanking #mergersandacquisitions #mergersacquisitionsdivestitures
To view or add a comment, sign in
-
As healthcare undergoes seismic shifts, the marriage of private equity and medical practices takes center stage. From financial injections to workforce dynamics, understanding private equity’s influence is crucial. In this guide, we cover the basics, weigh the pros and cons, and shed light on the path ahead.
In an era of transformative shifts, the convergence of private equity and healthcare has become a focal point. As private investors channel substantial capital into health care acquisitions, the implications ripple across patients, providers, and the very fabric of our healthcare system. In this basic guide, we explore the nuances of private equity, its impact, and the legal landscape surrounding these transactions. #PrivateEquity #Healthcare #PhysicianPractices #PatientCare #VentureCapital #RegulatoryScrutiny #HealthcareInvestments #HealthcareFinance #PrivateEquityInvestments #HealthcareTransformation #LegalImplications https://lnkd.in/e_-48Bjx
Private Equity in Healthcare: Transforming the Landscape - Taino Consultants
https://www.tainoconsultants.com
To view or add a comment, sign in